Mubadala Capital Ventures logo

Mubadala Capital Ventures

North America, California, United States, San Francisco

Description

Mubadala Capital Ventures is the dedicated venture capital arm of Mubadala Investment Company, a prominent sovereign investor based in Abu Dhabi. Operating globally with a significant presence in San Francisco, the firm strategically invests in disruptive technologies across various stages. Its mandate is to back innovative companies poised for significant growth, leveraging the extensive network and resources of its parent company. Mubadala Capital Ventures focuses on sectors such as artificial intelligence, enterprise software, fintech, health tech, and consumer internet, seeking out founders who are building the next generation of industry leaders.

The firm employs a multi-stage investment strategy, deploying capital through distinct funds tailored to different growth phases. For early-stage opportunities, Mubadala Capital Ventures has raised dedicated vehicles, including the $400 million Mubadala Ventures I fund launched in 2017, and subsequent funds. These early-stage investments typically target companies from Series A onwards, providing crucial capital and strategic guidance to help them scale. The firm is known for its long-term partnership approach, offering portfolio companies access to global markets and strategic relationships within Mubadala's vast ecosystem.

In addition to early-stage investments, Mubadala Capital Ventures has a robust growth equity practice. This is exemplified by the launch of its $750 million Mubadala Ventures IV fund in 2022, specifically designed to support more mature, high-growth companies. This growth fund allows the firm to make substantial follow-on investments in its successful portfolio companies or lead significant rounds for new, later-stage opportunities. Through its comprehensive investment approach, Mubadala Capital Ventures aims to be a value-add investor, providing not just capital but also operational expertise and global market access to accelerate the success of its portfolio.

Investor Profile

Mubadala Capital Ventures has backed more than 121 startups, with 1 new investments in the last 12 months alone. The firm has led 29 rounds, about 24% of its total and boasts 23 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A, Series B, Series C rounds (top funding stages).
  • Majority of deals are located in United States, Germany, United Kingdom.
  • Strong thematic focus on Health Care, Biotechnology, Software.
  • Typical check size: $1M – $75M.

Stage Focus

  • Series A (26%)
  • Series B (23%)
  • Series C (12%)
  • Series D (8%)
  • Seed (8%)
  • Post Ipo Equity (7%)
  • Series Unknown (7%)
  • Series E (5%)
  • Private Equity (3%)
  • Series F (1%)

Country Focus

  • United States (72%)
  • Germany (6%)
  • United Kingdom (5%)
  • China (3%)
  • Sweden (2%)
  • Austria (2%)
  • France (2%)
  • United Arab Emirates (2%)
  • Russian Federation (2%)
  • Switzerland (1%)

Industry Focus

  • Health Care
  • Biotechnology
  • Software
  • Therapeutics
  • Artificial Intelligence (Ai)
  • Information Technology
  • Medical
  • Life Science
  • Pharmaceutical
  • Financial Services
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Mubadala Capital Ventures frequently co-invest with?

Catalio Capital Management
North America, New York, United States, New York
Co-Investments: 6
SoftBank Vision Fund
Europe, England, United Kingdom, London
Co-Investments: 8
Google Ventures
North America, California, United States, Mountain View
Co-Investments: 12
Casdin Capital
North America, New York, United States, New York
Co-Investments: 9
Felicis
North America, California, United States, Menlo Park
Co-Investments: 9
Polaris Partners
North America, Massachusetts, United States, Boston
Co-Investments: 8
Lux Capital
North America, New York, United States, New York
Co-Investments: 7
Tiger Global Management
North America, New York, United States, New York
Co-Investments: 7
DCVC
North America, California, United States, San Francisco
Co-Investments: 7
ARCH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 9

Which angels does Mubadala Capital Ventures often collaborate with?

TF
Europe, Ile-de-France, France, Paris
Shared Deals: 2
MK
North America, California, United States, San Francisco
Shared Deals: 2
BA
North America, California, United States, Palo Alto
Shared Deals: 1
KH
North America, California, United States, San Francisco
Shared Deals: 2
JM
North America, California, United States, San Francisco
Shared Deals: 2
AG
North America, California, United States, Palo Alto
Shared Deals: 1
JH
North America, California, United States, San Francisco
Shared Deals: 2
KS
North America, California, United States, San Francisco
Shared Deals: 3
FB
North America, New York, United States, New York
Shared Deals: 2
MA
North America, United States
Shared Deals: 2

What are some of recent deals done by Mubadala Capital Ventures?

Auron Therapeutics

Newton, Massachusetts, United States

Auron aims to cure cancer therapeutics from cell killing to transformation of malignant cells into more normal functioning cells.

BiotechnologyHealth CareTherapeutics
Series BFeb 4, 2025
Amount Raised: $27,000,000
Firstvet

Stockholm, Stockholms Lan, Sweden

FirstVet is a digital veterinary platform that provides video consultation services for pet owners.

MedicalMobile AppsPetVeterinary
Series CJun 24, 2024
Amount Raised: $21,388,064
Storyblok

Linz, Oberosterreich, Austria

Storyblok is a content management system that specializes in the management of content experiences.

CMSIaaSInformation TechnologyInternetPaaSSoftwareWeb DesignWeb DevelopmentWeb Hosting
Series CJun 4, 2024
Amount Raised: $80,089,317
Arbol

New York, New York, United States

Arbol is a climate risk coverage company that offers solutions to analyze .and mitigate exposure to climate risk.

AgricultureAgTechArtificial Intelligence (AI)Big DataBlockchainInformation TechnologyInsuranceInsurTechMarketplaceSoftware
Series BApr 30, 2024
Amount Raised: $60,000,000
Metsera

New York, New York, United States

Metsera operates as a clinical-stage biopharmaceutical company.

BiopharmaHealth CareMedical
Series AApr 18, 2024
Amount Raised: $290,000,000
Flip

El Segundo, California, United States

Flip is a next-gen social & live commerce platform by combining a TikTok-like discovery experience with a premium e-commerce service.

BeautyE-CommerceRetailShoppingSocial Media
Series CApr 2, 2024
Amount Raised: $144,000,000
Capstan Therapeutics

San Diego, California, United States

Capstan Therapeutics is advancing cell engineering to develop therapeutics for a broad range of diseases.

BiotechnologyHealth CareTherapeutics
Series BMar 20, 2024
Amount Raised: $175,000,000
Truist Insurance Holdings

Charlotte, North Carolina, United States

Truist Insurance Holdings is a subsidiary of Truist Financial Corporation and the sixth-largest insurance brokerage.

Insurance
Private EquityFeb 20, 2024
Rejuveron Life Sciences

Schlieren, Zurich, Switzerland

Rejuveron Life Sciences is a fully integrated biotechnology platform company that invests in people and ideas to develop therapies.

BiotechnologyHealth CareMedical
Series BSep 13, 2023
Amount Raised: $75,000,000
Georgiamune

Gaithersburg, Maryland, United States

Georgiamune is a biotechnology company developing next-generation immunotherapeutics for cancer and autoimmune diseases.

BiotechnologyHealth CareTherapeutics
Series AAug 9, 2023
Amount Raised: $75,000,000